Wednesday, December 17, 2008

Janssen-Cilag International N.V. Withdraws its Application for an Extension of Indication for Invega

Dec. 17, 2008-The European Medicines Agency has been formally notified by Janssen-Cilag International N.V. of its decision to withdraw its application for an extension of indication for the centrally authorised medicine Invega (paliperidone) prolonged-release tablets.

The details can be read here.

No comments: